NHS Wales will hand out ID cards to people who get a coronavirus vaccine to help them prove they have had the jab.
A two-dose vaccine developed by Pfizer and BioNTech will be rolled out from next week after the UK became the first nation to approve the jab for emergency use.
For months there has been talk of Britons being given ID cards or "passports" to show as proof they have been vaccinated against Covid-19.
Wales' Health Minister Vaughan Gething confirmed on Wednesday that people there will receive a credit-card sized immunisation card which states the type of vaccine and the date it was administered, WalesOnline reports.
Cabinet Office Minister Michael Gove has said there are no plans for a "vaccine passport" in England for access to venues such as pubs and restaurants.
Click here for our live blog with the latest updates on the Pfizer vaccine and Covid-19 pandemic.
Mr Gething said: "Those receiving a Covid-19 vaccination will be given a credit card-sized NHS Wales immunisation card which will have the vaccine name, date of immunisation and batch number of each of the doses given handwritten on them.
"These will act as a reminder for a second dose and for the type of vaccine, and it will also give information about how to report side effects."
Asked if there would be a vaccine passport, Mr Gove told Sky News on Tuesday: "No, that's not being planned.
"I certainly am not planning to introduce any vaccine passports and I don't know anyone else in Government..."
He added: "I think the most important thing to do is make sure that we vaccinate as many people as possible."
His comments came after UK Health Minister Nadhim Zahawi, who is in charge of the rollout of Covid-19 vaccines, suggested that a so-called "immunity passport" was being looked at to identify people who had the jab.
Mr Zahawi said that hospitality and entertainment venues might insist on seeing such a "passport" from customers.
The Health Minister said that the Government was "looking at the technology" so people could show that they had a Covid-19 vaccine.
He said: "I think you'll probably find that restaurants and bars and cinemas and other venues, sports venues, will probably also use that system - as they have done with the (test and trace) app."
Meanwhile, NHS trusts in Wales have carried out simulation exercises to test the distribution and storage arrangements of the vaccine.
Experts have expressed concerns that storing and transporting the Pfizer-BioNTech vaccine might prove to be difficult.
It must be kept at temperatures below -70C for it to remain chemically stable and still work when it is injected.
As it emerged on Wednesday that the UK has approved the Pfizer and BioNTech vaccine, UK Health Secretary Matt Hancock declared Britain will be through Covid-19 "by spring".
The jab has been shown in studies to be 95% effective and works in all age groups.
The UK has ordered 40million doses of the vaccine, enough to vaccinate 20million people - or about a third of the population - with two doses, given 21 days apart.
Around 10million doses are expected to be available for use in the UK in the coming weeks for priority groups, including healthcare workers, with 800,000 doses arriving next week.
Vaccines developed by Moderna and AstraZeneca/Oxford University could be given emergency use approval soon.
The UK has secured access to 100million doses of the AstraZeneca/Oxford University vaccine, which is almost enough for most of the population.
It also belatedly struck a deals for seven million doses of the jab on offer from Moderna in the US.
The deals cover four different classes: adenoviral vaccines, mRNA vaccines, inactivated whole virus vaccines and protein adjuvant vaccines.
The UK has secured access to:
- 100million doses of the Oxford vaccine
- 60million doses of the Novavax vaccine
- Some 30million doses from Janssen
- 40million doses of the Pfizer/BioNTech vaccine - the first agreement the firms signed with any government
- 60million doses of a vaccine being developed by Valneva
- 60million doses of protein adjuvant vaccine from GlaxoSmithKline (GSK) and Sanofi Pasteur
- Seven million doses of the jab on offer from Moderna in the US.
